Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis

Eur J Clin Microbiol Infect Dis. 2023 Dec;42(12):1543-1545. doi: 10.1007/s10096-023-04685-8. Epub 2023 Oct 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Hepatitis B Surface Antigens
  • Hepatitis B virus*
  • Humans
  • Lamivudine / pharmacology
  • Virus Activation

Substances

  • Lamivudine
  • Antiviral Agents
  • Hepatitis B Surface Antigens